Screening for mutations in 17β-hydroxysteroid dehydrogenase and androgen receptor in women presenting with partially virilised 46,XY disorders of sex development
- 1 June 2015
- journal article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 172 (6), 745-751
- https://doi.org/10.1530/eje-14-0994
Abstract
Context and objective: The precise diagnosis of partially virilised women with 46,XY disorders of sex development (DSD) is often obscure. In practice, this group often comes under the poorly defined, clinically based label of partial androgen insensitivity syndrome (PAIS). In a previous study, we found that 5α-reductase 2 (SRD5A2) mutations occurred in 43% of women in this subgroup. We expand this work to include biochemical and genetic screening for 17β-hydroxysteroid dehydrogenase (HSD17B3) and androgen receptor (AR) mutations.Methods: Analysis of serum androgens (androstenedione and testosterone) and genetic analyses for HSD17B3 and AR were performed in 42 women from 36 pedigrees with partially virilised 46,XY DSD in whom SRD5A2 deficiency had been excluded by urine steroid profiling.Results: Out of 36 unrelated women, 14 (38%) were found to have HSD17B3 mutations and one (2.7%) to have an AR defect. Six novel pathogenic HSD17B3 mutations were identified: three splice site mutations and three missense changes. Seven patients with HSD17B3 deficiency tested before gonadectomy had basal testosterone/androstenedione (T/A) ratio HSD17B3 must be performed to confirm the diagnosis.Keywords
This publication has 24 references indexed in Scilit:
- Androgen insensitivity syndromeThe Lancet, 2012
- Novel (60%) and Recurrent (40%) Androgen Receptor Gene Mutations in a Series of 59 Patients with a 46,XY Disorder of Sex DevelopmentJournal of Clinical Endocrinology & Metabolism, 2010
- Depot‐specific steroidogenic gene transcription in human adipose tissueClinical Endocrinology, 2008
- Genotype Versus Phenotype in Families with Androgen Insensitivity SyndromeJournal of Clinical Endocrinology & Metabolism, 2001
- Phenotypic Features, Androgen Receptor Binding, and Mutational Analysis in 278 Clinical Cases Reported as Androgen Insensitivity SyndromeJournal of Clinical Endocrinology & Metabolism, 2000
- 17 -Hydroxysteroid Dehydrogenase-3 Deficiency: Diagnosis, Phenotypic Variability, Population Genetics, and Worldwide Distribution of Ancient and de Novo MutationsJournal of Clinical Endocrinology & Metabolism, 1999
- Characteristics of a Highly Labile Human Type 5 17 -Hydroxysteroid DehydrogenaseEndocrinology, 1999
- Physiology and molecular genetics of 17β-hydroxysteroid dehydrogenasesSteroids, 1997
- Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiencyJournal of Clinical Endocrinology & Metabolism, 1996
- Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3Nature Genetics, 1994